Smith PD - Search Results

1

Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice.

Crocker SJ, Liston P, Anisman H, Lee CJ, Smith PD, Earl N, Thompson CS, Park DS, Korneluk RG, Robertson GS. Crocker SJ, et al. Among authors: smith pd. Neurobiol Dis. 2003 Mar;12(2):150-61. doi: 10.1016/s0969-9961(02)00020-7. Neurobiol Dis. 2003. PMID: 12667469

2

c-Jun mediates axotomy-induced dopamine neuron death in vivo.

Crocker SJ, Lamba WR, Smith PD, Callaghan SM, Slack RS, Anisman H, Park DS. Crocker SJ, et al. Among authors: smith pd. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13385-90. doi: 10.1073/pnas.231177098. Epub 2001 Oct 30. Proc Natl Acad Sci U S A. 2001. PMID: 11687617 Free PMC article.

3

Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.

Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. Crocker SJ, et al. Among authors: smith pd. J Neurosci. 2003 May 15;23(10):4081-91. doi: 10.1523/JNEUROSCI.23-10-04081.2003. J Neurosci. 2003. PMID: 12764095 Free PMC article.

4

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.

Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O'Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS. Smith PD, et al. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13650-5. doi: 10.1073/pnas.2232515100. Epub 2003 Oct 31. Proc Natl Acad Sci U S A. 2003. PMID: 14595022 Free PMC article.

5

Emerging pathogenic role for cyclin dependent kinases in neurodegeneration.

Smith PD, O'Hare MJ, Park DS. Smith PD, et al. Cell Cycle. 2004 Mar;3(3):289-91. Epub 2004 Mar 1. Cell Cycle. 2004. PMID: 14726693

6

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS. Hayley S, et al. Among authors: smith pd. J Neurosci. 2004 Feb 25;24(8):2045-53. doi: 10.1523/JNEUROSCI.4564-03.2004. J Neurosci. 2004. PMID: 14985447 Free PMC article.

7

CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease.

Smith PD, O'Hare MJ, Park DS. Smith PD, et al. Trends Mol Med. 2004 Sep;10(9):445-51. doi: 10.1016/j.molmed.2004.07.003. Trends Mol Med. 2004. PMID: 15350897 Review. No abstract available.

8

BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.

Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, Thorarinsdottir TE, Glover JR, Fon EA, Park DS, Lozano AM. Kalia SK, et al. Among authors: smith pd. Neuron. 2004 Dec 16;44(6):931-45. doi: 10.1016/j.neuron.2004.11.026. Neuron. 2004. PMID: 15603737 Free article.

9

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW. Kim RH, et al. Among authors: smith pd. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5215-20. doi: 10.1073/pnas.0501282102. Epub 2005 Mar 22. Proc Natl Acad Sci U S A. 2005. PMID: 15784737 Free PMC article.

10

Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase.

Crocker SJ, Hayley SP, Smith PD, Mount MP, Lamba WR, Callaghan SM, Slack RS, Park DS. Crocker SJ, et al. Among authors: smith pd. J Neurochem. 2006 Jan;96(2):489-99. doi: 10.1111/j.1471-4159.2005.03568.x. Epub 2005 Nov 29. J Neurochem. 2006. PMID: 16336220 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

579 results

Search Page